Wilmington PharmaTech ("Wilmington"), a leading U.S.-based research, development, and manufacturing organization (CRDMO) focused on complex custom small-molecule API production, today announced a $50 ...
SK pharmteco today announced the successful conclusion of a regulatory inspection of its small molecule North America facility in La Porte, Texas. The U.S. Food and Drug Administration (FDA) carried ...
qualified companies can utilize one or more of three established pharmaceutical manufacturing plants on the campus under a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results